NLR has been reported to correlate well with serum CRP levels [12] and to predict oncological outcomes in patients with RCC [12], nonclear cell RCC [13], and upper tract urothelial cell carcinoma [14]. The gene discussed is CRP; the disease is renal cell carcinoma.